DRUG · Unmapped registry intervention
MP-376
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT00739648
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Amgenlead sponsor
Mapped research locations
San AntonioTexas, United States1San DiegoCalifornia, United States1ColumbusOhio, United States1PhoenixArizona, United States1OrlandoFlorida, United States1OmahaNebraska, United States1RichmondVirginia, United States1New OrleansLouisiana, United States1Long BeachCalifornia, United States1BuffaloNew York, United States1Palo AltoCalifornia, United States1SpartanburgSouth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00739648 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.